Maureen Edgerly
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Co-authors
- Tito Fojo (16 shared papers)Susan E. Bates (13 shared papers)Frank M. Balis (7 shared papers)Manish Agrawal (4 shared papers)Jame Abraham (3 shared papers)Herb Kotz (8 shared papers)Ann Rutt (3 shared papers)Susan Bakke (3 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)The Oncologist (3 papers)Clinical Cancer Research (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)The Cancer Journal (2 papers)
- Partner nations
- United StatesChileGermany
In The Last Decade
Maureen Edgerly
27 papers receiving 778 citations
Peers
Comparison fields: 5 of 63
- Oncology 404
- Cancer Research 153
- Genetics 74
- Virology 22
- Surgery 193
Countries citing papers authored by Maureen Edgerly
This map shows the geographic impact of Maureen Edgerly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Edgerly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Edgerly more than expected).
Fields of papers citing papers by Maureen Edgerly
This network shows the impact of papers produced by Maureen Edgerly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Edgerly. The network helps show where Maureen Edgerly may publish in the future.
Co-authors
The 25 scholars most cited alongside Maureen Edgerly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 113 | |
| 2 | Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. | 2003 | 105 |
| 3 | 2009 | 94 | |
| 4 | 2014 | 82 | |
| 5 | 2005 | 61 | |
| 6 | 2008 | 46 | |
| 7 | 2010 | 34 | |
| 8 | 2009 | 33 | |
| 9 | 2009 | 31 | |
| 10 | 2013 | 29 | |
| 11 | 2001 | 27 | |
| 12 | 2005 | 23 | |
| 13 | 2015 | 22 | |
| 14 | 2020 | 19 | |
| 15 | 2018 | 16 | |
| 16 | 2014 | 12 | |
| 17 | 2003 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2005 | 7 |
About Maureen Edgerly
Maureen Edgerly is a scholar working on Oncology, Surgery, Cancer Research, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 798 indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (10 papers), Cancer Treatment and Pharmacology (9 papers), Cancer, Hypoxia, and Metabolism (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Genomics and Diagnostics (2 papers), Microtubule and mitosis dynamics (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (404 citations), Cancer Research (153 citations), Genetics (74 citations), Virology (22 citations) and Surgery (193 citations). Maureen Edgerly has collaborated with scholars based in United States, Chile and Germany. Frequent co-authors include Tito Fojo, Susan E. Bates, Frank M. Balis, Manish Agrawal, Jame Abraham, Herb Kotz, Ann Rutt, Susan Bakke, Wilfred D. Stein and Christine Grady. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Clinical Cancer Research, The Journal of Clinical Endocrinology & Metabolism and The Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.